Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Icon (ICLR) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Camizestrant, Ribociclib, Azd9833Er-Positive Her2-Negative Breast CancerPhase IIIRecruitingA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerMay 12, 2026―
AnifrolumabSystemic Lupus ErythematosusPhase IIIRecruitingA Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusFeb 02, 2026
Jynneos, Mva-BnMonkeypox (Mpox)Phase IIRecruitingComparability Trial of the MVA-BN Vaccine Manufactured in Different Production CellsSep 22, 2025
PetrelintideRenal ImpairmentPhase ICompletedPharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal FunctionJul 10, 2025
Kedrion Ivig 10%Chronic Primary Immune Thrombocytopenia (Itp)Phase IIIRecruitingA Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)Jun 18, 2025
BelimumabBronchial DiseasesPhase IIIRecruitingA Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung DiseaseNov 29, 2024―
Mtx-463HealthyPhase ICompletedA First-in-Human Safety Trial of MTX-463Apr 22, 2024―
H1 Influenza AntigenInfluenzaPhase ICompletedPhase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAPOct 30, 2023―
Prx-102 1 Mg/Kg Every Two WeeksFabry Diseasephase2AndPhase3RecruitingA Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry DiseaseAug 10, 2023―
Jcxh-105, Active ControlInfectious Disease, Herpes Zoster (Hz), ShinglesPhase ICompletedA First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccineMay 03, 2023―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Icon Plc (ICLR) have in its pipeline
Icon ICLR is currently developing the following drugs: Camizestrant, Ribociclib, Azd9833, Anifrolumab, Jynneos, Mva-Bn, Petrelintide, Kedrion Ivig 10%, Belimumab, Mtx-463, H1 Influenza Antigen, Prx-102 1 Mg/Kg Every Two Weeks, Jcxh-105, Active Control, Jcxh-221, Altb-268, Sp-420, Prx-102 1 Mg/Kg Every 2 Weeks, Prx-102 2 Mg/Kg Every 4 Weeks, Mt1980, Bxq-350, Fp-101, Mrx0029, Mrx0005, Vudalimab, Imgatuzumab, Leo 153339, Mb-Cart2019.1, R-Gemox Or Br Plus Polatuzumab Vedotin, Autologous Genetically Modified Adp-A2m4cd8 Cells, Mrg-001, Pembrolizumab, Pemetrexed, Tomivosertib, Xmab18087, Xmab18087 ± Pembrolizumab, Allob, Vortioxetine, Probiotic, Autologous Genetically Modified Adp-A2m4cd8 Cells Alone Or In Combination With Nivolumab Every Four Weeks Or Pembrolizumab Every 6 Weeks, Mb-Cart2019.1 Dose Level 1, Mb-Cart2019.1 Dose Level 2, Xanamem, Xmab23104, Yervoy, Rjx, Xmab20717, Sernova Cell Pouch, Xmab18087, Pegfilgrastim, Plinabulin, Saline, Vas203, Ecn-Suspension. These drug candidates are in various stages of clinical development as the company works toward FDA approval.